ZNTL

Zentalis Pharmaceuticals, Inc.

Company with tickers: ZNTL

CIK

1725160

CUSIP

98943L107

Shares Outstanding

71,186,348

Website

https://www.zentalis.com

Investor Relations

https://ir.zentalis.com/overview/default.aspx

13F Activity (30d)

2 filings 1 filers

Press releases and events scraped from the company's investor relations website. News and event listings link back to the original source.

Date	Headline
2026-06-01	Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
2026-05-27	Zentalis Strengthens Commercial Leadership with Appointments of Shannon Campbell to Board of Directors and Sarah Kelly as SVP of Commercial Strategy
2026-05-21	Zentalis Pharmaceuticals to Present Phase 1b MUIR Trial Data Showing Encouraging Clinical Activity and Manageable Safety Profile of Azenosertib Plus Paclitaxel in Platinum-Resistant Ovarian Cancer at ASCO 2026
2026-05-13	Zentalis Pharmaceuticals to Participate in Upcoming Investor Conferences
2026-05-12	Zentalis Pharmaceuticals Reports First Quarter 2026 Financial Results and Clinical Progress
2026-05-05	Zentalis Pharmaceuticals Announces First Patient Dosed in ASPENOVA Phase 3 Trial of Azenosertib in Patients with Cyclin E1-Positive Platinum-Resistant Ovarian Cancer
2026-05-01	Zentalis Pharmaceuticals Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
2026-04-21	Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer
2026-04-17	Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026
2026-04-09	Zentalis Pharmaceuticals Announces 400mg QD 5:2 Azenosertib Monotherapy as the Pivotal Study Dose in Cyclin E1-Positive Platinum-Resistant Ovarian Cancer

Date	Event	Type
2026-06-03	Jefferies Global Healthcare Conference in New York	Conference
2026-05-26	TD Cowen's 7th Annual Oncology Innovation Summit: Insights for ASCO & EHA	Event
2026-05-20	Stifel 2026 Virtual Oncology Forum	Event
2026-05-19	H.C. Wainwright 4th Annual BioConnect Conference at Nasdaq	Conference
2026-03-09	Leerink Global Healthcare Conference	Conference
2026-03-03	TD Cowen 46th Annual Health Care Conference	Conference
2026-02-25	Oppenheimer 36th Annual Healthcare Life Sciences Conference	Conference
2026-02-11	Guggenheim Emerging Outlook: Biotech Summit 2026	Event
2025-11-12	Stifel 2025 Healthcare Conference	Conference
2025-11-11	Guggenheim 2nd Annual Healthcare Innovation Conference	Conference
2025-09-09	Morgan Stanley 23rd Annual Global Healthcare Conference	Conference
2025-09-08	H.C. Wainwright 27th Annual Global Investment Conference	Conference
2025-09-04	2025 Wells Fargo Healthcare Conference	Conference